LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$9.15
-0.13 (-1.40%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+52.8% upside
Low Target
$9.74
Average Target
$13.98
High Target
$16.17
Current Price
$9.15
Current
$9.15
$9.15
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Scenario Analysis
Bear Case
$9.74
6.4%
Low target
Base Case
$13.98
+52.8%
Avg target
Bull Case
$16.17
+76.7%
High target
Risk/Reward
11.9x
Highly favorable
Price in Context
52-Week High
$50.40
-81.8% from high
52-Week Low
$8.25
+10.9% from low
Target vs 52W High
$13.98
-72.3% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-1.09
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals